MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Discrimination of Parkinson’s disease participants from healthy controls using telephone-quality voice recordings

S. Arora, A. Tsanas (Oxford, United Kingdom)

Meeting: 2016 International Congress

Abstract Number: 820

Keywords: Parkinsonism

Session Information

Date: Tuesday, June 21, 2016

Session Title: Parkinson's disease: Pathophysiology

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To test the practicality and efficacy of telephone-quality voice recordings to discriminate Parkinson’s disease (PD) participants from healthy controls (HC).

Background: Vocal performance degradation is met in the vast majority of people diagnosed with PD, and may be one of the earliest indicators of disease onset. Using high-quality voice recordings, recent studies have developed technologies both to discriminate PD from HC, and also for symptom severity telemonitoring. However, these studies may be limited in scaling massively across the population as they rely on expensive specialized equipment to collect the data, which might not be available in resource-constrained settings. In this study, we investigated whether telephone-quality voice recordings collected using readily available standard commercial consumer phones could be used to provide easily accessible, cost-effective means towards accurate PD assessment.

Methods: We collected sustained vowel phonations (‘aaah’ sounds, where the subject is requested to keep the pitch and amplitude as steady as possible) through telephone-quality digital audio lines, under realistic, non-lab conditions. The recordings were obtained from the following locations: Argentina, Brazil, Canada, Spain, Mexico, UK and USA. After screening out bad recordings, we used 2799 recordings from 1507 PD participants (mean age: 50.9 years, 45.9% female), and 15486 recordings from 8394 control participants (mean age: 51.1 years, 45.0% female). We extracted and analyzed 309 dysphonia measures to quantify subtle changes in the recorded signals, which can differentiate PD from HC voices. We presented the dysphonia measures to a random forest classifier, and assessed the efficacy of the model using 10-fold cross-validation with 100 iterations for statistical confidence.

Results: Using only the voice recordings, we achieved a mean out of sample sensitivity of 63.8% (standard deviation 2.3%) and mean specificity of 67.2% (standard deviation 2.9%) in discriminating PD from HC.

Conclusions: The discrimination results obtained are promising and are considerably better than standard naïve benchmarks (or chance). These findings warrant further investigation into the feasibility of using voice as a potential biomarker of PD, even with low-quality telephone-based recordings.

To cite this abstract in AMA style:

S. Arora, A. Tsanas. Discrimination of Parkinson’s disease participants from healthy controls using telephone-quality voice recordings [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/discrimination-of-parkinsons-disease-participants-from-healthy-controls-using-telephone-quality-voice-recordings/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/discrimination-of-parkinsons-disease-participants-from-healthy-controls-using-telephone-quality-voice-recordings/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley